MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • MDS Virtual Congress 2021

    “I’ve got cataracts and can’t read the information sheet about the medication you have given me”*

    P. Hobson, V. Adhiyaman (Rhyl, United Kingdom)

    Objective: This study reports People with Parkinson’s (PWP) perception on their illness, its meaning to them and their view of the interactions they have with…
  • MDS Virtual Congress 2021

    Identifying and Controlling Variability in Digital Health Measures in Parkinson’s disease Clinical Trials

    G. Roussos, R. Bhatnagar, J. Burton, J. Cosman, A. Derungs, A. Dowling, K. Fisher, D. Hill, K. Praneeth Kilambi, L. Evers, N. Mehrotra, M. Minchik, M. Muller, T. Ruiz Herrero, S. Sardar, D. Stephenson (London, United Kingdom)

    Objective: The 3DT initiative of the Critical Path for Parkinson’s Consortium (CPP) aims to advance the regulatory maturity of digital biomarkers, for clinical studies in…
  • MDS Virtual Congress 2021

    Impact of 3-month earlier versus postponed initiation of opicapone versus entacapone in levodopa-treated patients with Parkinson’s disease and motor fluctuations

    C. Carroll, A. Lees, J. Ferreira, M. Fonseca, D. Magalhaes, J. Rocha, P. Soares-da-Silva (Plymouth, United Kingdom)

    Objective: This post-hoc analysis evaluated the impact of 3-month earlier versus postponed initiation of opicapone (OPC) in patients with Parkinson’s disease (PD) and motor fluctuations.…
  • MDS Virtual Congress 2021

    Effects of Opicapone on Sleep in Patients with Parkinson’s Disease and Motor Fluctuations

    R. Hauser, A. Videnovic, P. Soares-da-Silva, G. Liang, K. Olson, E. Jen, JF. Rocha, O. Klepitskaya (Miami, USA)

    Objective: To assess the effects of opicapone (OPC: 50 mg, once-daily) on sleep in patients with Parkinson’s disease (PD) and motor fluctuations. Background: OPC is…
  • MDS Virtual Congress 2021

    A new fully implantable Adaptive Deep Brain Stimulation system tested for the first time in patients with Parkinson’s Disease

    T. Mandat, R. Eleopra, M. Lanotte, L. Lopiano, M. Yanssen, Y. Temel, E. Pirola, P. Rampini (Warsaw, Poland)

    Objective: This multicenter double-blind crossover study has been designed to evaluate the safety and efficacy of adaptive Deep Brain Stimulation delivered through an innovative IPG…
  • MDS Virtual Congress 2021

    The Impact of Visual Cueing on Gait Velocity in those with Parkinson’s Disease with Freezing of Gait

    M. Scavarda, K. Nagel, D. Peterson, K. Plesher, S. Moskowitz, C. Ivy, L. Denney (Phoenix, USA)

    Objective: To determine the ease of use and preliminary effectiveness of shoe-mounted visual cue (laser) on gait velocity in those with Parkinson’s Disease and freezing…
  • MDS Virtual Congress 2021

    The early post-transplant period in Parkinson’s disease: the low intravenous dose effect.

    V. Chyzhyk, V. Ponomarev, N. Aleinikava, A. Boika, M. Zafranskaya, D. Nizheharodava (Minsk, Belarus)

    Objective: To compare the early results of the introduction of MSCs via different routs of administration on the dynamics of the motor symptoms in patients…
  • MDS Virtual Congress 2021

    Evaluating a Novel Home-Based Care Pathway for People with Parkinson’s Disease

    E. King, J. Abraham, E. Edwards, T. Gorst, M. Holley, J. Inches, T. North, J. Rideout, S. Whipps, C. Carroll (Plymouth, United Kingdom)

    Objective: To evaluate the acceptability, feasibility, safety and effectiveness of a novel remotely delivered Parkinson’s care pathway. Background: Current care pathways for people with Parkinson’s…
  • MDS Virtual Congress 2021

    A French national multicentric prospective study of the 1-year impact of STN-DBS on speech in Parkinson’s disease: profile of progression and prognostic factors.

    T. Ollivier, S. Pinto, R. Viard, G. Kuchcinski, G. Touzet, L. Defebvre, D. Devos, C. Moreau (Lille, France)

    Objective: 1) To describe the evolution of speech in a large cohort of patients before and 1 year after STN-DBS. 2) To search for preoperative…
  • MDS Virtual Congress 2021

    The Transcriptome from Multiple Regions of the MPTP-induced Parkinson’s disease Mouse Brain after exercise

    T. Tong, Z. Zhang, Z. Zhang, H. Hu, L. Li, J. Jin (Shanghai, China)

    Objective: To illuminate the respective functions of substantia nigra, striatum, cortex and cerebellum in Parkinson's motor improvement following exercise training in a chronic MPD (MPTP…
  • « Previous Page
  • 1
  • …
  • 506
  • 507
  • 508
  • 509
  • 510
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley